ADCO PANTOPRAZOLE IV
Pantroprazole Sodium Sesquihydrate equivalent to Pantroprazole
What it does
Pantoprazole is a medication that reduces stomach acid, helping to treat various digestive issues.
Commonly used for: stomach ulcers, gastroesophageal reflux disease (GERD), excess stomach acid conditions
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:12:36 · updated 2026-09-23 04:10:46
About pantroprazole
Pantoprazole is a medication that reduces stomach acid, helping to treat various digestive issues.
What it treats
- stomach ulcers
- gastroesophageal reflux disease (GERD)
- excess stomach acid conditions
How it works
It works by blocking the pumps in the stomach that produce acid, leading to less acid and relief from symptoms.
Who it's for
This medicine is for adults and children over 12 who need help with acid-related stomach problems.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About sesquihydrate
Sesquihydrate is a compound often used in various formulations, but specific information about its uses and interactions is limited.
How it works
The exact mechanism of how sesquihydrate works is not well-defined, but it is often included in formulations to improve texture or stability.
Who it's for
Sesquihydrate is generally used in products for individuals needing certain formulations, but specific patient groups are not identified.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: pantroprazole
Pantoprazole is a proton pump inhibitor (PPI) that decreases stomach acid production. It is commonly used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. By inhibiting the H+/K+ ATPase enzyme in the gastric parietal cells, pantoprazole effectively reduces the secretion of gastric acid.
Indications
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
- Zollinger-Ellison syndrome
- Prevention of stress ulcer bleeding
Dosage
Children: Refer to the BNF for Children for specific dosing information.
Adults: Refer to the BNF for specific dosing information.
Mechanism of action
Pantoprazole works by irreversibly binding to the H+/K+ ATPase enzyme, also known as the gastric proton pump, located on the luminal surface of the gastric parietal cells. This action inhibits the final step of gastric acid secretion, leading to a significant reduction in gastric acidity.
Pharmacodynamics
Pantoprazole exhibits a dose-dependent inhibition of gastric acid secretion. The onset of action is typically within 1 hour, with peak effects observed around 2 to 4 hours post-administration. The duration of action can last up to 24 hours. Pantoprazole is more effective in inhibiting gastric acid secretion in a stimulated state, such as after meal intake.
Pharmacokinetics
Pantoprazole is well absorbed from the gastrointestinal tract, with bioavailability being around 77% when taken orally. It undergoes extensive hepatic metabolism, primarily via the cytochrome P450 system, particularly CYP2C19 and CYP3A4. The elimination half-life is approximately 1 hour, but its effects on acid secretion can last much longer due to the irreversible action on the proton pump. Excretion occurs mainly via the urine, with around 80% of the drug being eliminated as metabolites.
Contra-indications
- Hypersensitivity to pantoprazole or any component of the formulation
- Concomitant use with nelfinavir
Adverse effects
- Headache
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Flatulence
- Constipation
- Rash
- Dizziness
- Fatigue
Interactions
- May reduce the effectiveness of drugs that require an acidic gastric pH for absorption (e.g., ketoconazole, atazanavir)
- May interact with warfarin and increase the risk of bleeding
- Concomitant use with methotrexate may increase the risk of toxicity
Precautions
- Use with caution in patients with hepatic impairment
- Long-term use may lead to vitamin B12 deficiency
- Monitor for signs of Clostridium difficile-associated diarrhea
- Consider potential risk of gastric cancer in long-term use
Pregnancy
Pantoprazole should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited data on human use.
Breast-feeding
Pantoprazole is excreted in human milk, caution should be exercised when administering to nursing women.
Storage
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Formulations
- Tablets (Enteric-coated)
- Injection (Powder for solution)
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: sesquihydrate
Sesquihydrate refers to a hydrate form of a compound that contains one and a half molecules of water for every molecule of the compound. It is commonly associated with various medications that may appear in this hydrated form. The specific pharmacological properties and clinical applications depend on the base compound of the sesquihydrate form, which can vary widely.
Dosage
Children: For paediatric dosing information, refer to the specific drug associated with the sesquihydrate form, as dosages will vary based on the active ingredient.
Adults: For dosing information, refer to the specific drug associated with the sesquihydrate form, as dosages will vary based on the active ingredient.
Mechanism of action
The mechanism of action of a sesquihydrate compound is dependent on the active ingredient it is associated with. Generally, hydrated forms of drugs may influence solubility and bioavailability, affecting how the drug interacts with biological systems.
Pharmacodynamics
Pharmacodynamics will vary significantly according to the specific sesquihydrate compound. Typically, the pharmacodynamic profile would include the drug's effects on the body, the relationship between drug concentration and effect, and the duration of action, which are influenced by its chemical structure and interactions with target receptors or enzymes.
Pharmacokinetics
Pharmacokinetics of a sesquihydrate compound is influenced by its solubility, absorption, distribution, metabolism, and excretion (ADME). The presence of water molecules in the sesquihydrate form can enhance solubility, potentially improving absorption. The specific pharmacokinetic parameters would need to be referenced from studies of the particular drug associated with the hydrated form.
Pregnancy
Consult a healthcare provider before use.
Breast-feeding
Consult a healthcare provider before use.
Storage
Store in a cool, dry place away from direct sunlight.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- PAN IV · East African Overseas
- PANTIN · Aspiro Pharma
- PANTIN 40 · Hetero Labs
- PANTOPRAZOLE
- PANTOPRAZOLE · Beximco Pharmaceuticals
- PANTORAN-40 TABLETS · Bafna Pharmaceuticals Limited
- DEMOPAN · Tata Africa Holdings
- DOMIPAN · Simba Pharmaceuticals
- DOPAM · Dawa
- PANOPAZ TABLETS · Sai Pharmaceuticals
- PANTEL TABLETS · Quest Pharmaceuticals
- PANTIN 40 · Unisel